24/7 Market News Snapshot 20 October, 2025 – 10x Genomics, Inc. Class A Common Stock (NASDAQ:TXG)

October 20, 2025

DENVER, Colo., 20 October, 2025 (www.247marketnews.com) – (NASDAQ:TXG) are discussed in this article.
10x Genomics, Inc. has made headlines recently for both its stock performance and its groundbreaking collaboration with Anthropic, a leader in AI research. The company’s Class A Common Stock (TXG) opened at $11.91 and is currently trading at $13.07, reflecting a notable intraday gain of 10.48% compared to a previous close at $11.83. The surge in trading volume, with 4.42 million shares exchanged, suggests strong investor interest and a potential bullish outlook. Analysts note that the stock’s price has crossed above key moving averages, indicating possible further appreciation. Market watchers should keep an eye on the support level around $12.50 and the resistance level at approximately $13.50, as they assess the potential for advantageous long positions.

In conjunction with this positive market activity, 10x Genomics has announced an innovative partnership with Anthropic to enhance the integration of AI within life sciences. This collaboration aims to incorporate 10x’s single-cell and spatial biology tools into Anthropic’s newly developed Claude for Life Sciences platform. This new interface enables researchers to navigate complex datasets using natural language, drastically simplifying the analysis process that previously demanded significant computational expertise.

The introduction of the Model Context Protocol (MCP) allows scientists to perform crucial analyses—such as aligning reads and generating Feature Barcode matrices—by merely inputting queries in plain English. This advancement exemplifies a significant leap forward in making biological data analysis more accessible and user-friendly.

Serge Saxonov, Co-Founder and CEO of 10x Genomics, expressed excitement over the partnership, highlighting the removal of technical barriers as a means to empower researchers in discovery. The collaboration underscores a commitment to accelerating scientific breakthroughs and advancing the field of health and disease understanding through innovative exploration facilitated by AI. As the life sciences sector evolves, this synergy between cutting-edge technology and biological research positions both companies at the forefront of transformative developments in scientific inquiry.

Related news for (TXG)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.